Polymer solutions firm Foster Corporation has announced a new partnership with masterbatch player LioChem.
LioChem aim to serve to augment, and expand, Foster’s current capability in supply of medical colour masterbatch by offering larger volume capability as well as providing expertise in critical colour matching situations.
LioChem’s LioplaxMD colour masterbatch products are custom formulated and manufactured exclusively for the critical medical device market using FDA approved 21 CFR 73 Subpart D pigments.
Marcela Linares, Foster’s market development manager, said: “LioChem are experts in colour, and colour masterbatch products. Because of this expertise they can provide knowledgeable technical support to potential customers looking for guidance regards their medical colour needs. The company’s extensive experience with pigments, additives, and resins provides a unique opportunity to support design, prototyping, and production in large and small volumes for critical applications.
“The medical market for colour is growing at a brisk rate and, at the same time, medical colour needs are getting more complex. With the addition of the LioChem partnership, we will strengthen our capabilities and expand our offerings to satisfy the colour compound needs of our customers; which will enable them to get to market faster with the confidence that their products will comply with the regulatory needs that the medical device industry requires.”
Applications for Lioplax MD masterbatch products include medical housings, surgical instruments, fluid management, dialysis, packaging, medical tubing, respiratory & anaesthesiology, endoscopy, labware as well as other medical application segments.
